Uscátegui Rosa Magdalena, Correa Adriana M, Carmona-Fonseca Jaime
Grupo de Investigación en Alimentación y Nutrición Humana, Escuela de Nutrici6n y Dietetica, Universidad de Antioquia, Medellín, Colombia.
Biomedica. 2009 Jun;29(2):270-81.
Malaria, anemia and intestinal parasitism can co-exist in certain populations of Colombian children. The effects of retinol supplementation and anti-intestinal parasite treatment in children with malaria is unknown. Changes after this treatment of with respect to hemoglobin, retinol, ferritin and C reactive protein levels have not been previously monitored.
The effect of simultaneous intervention with antimalarial, retinol supplementation and anti-intestinal parasites treatment will be monitored by examining levels of hemoglobin, ferritin, retinol and C reactive protein in children with malaria.
A non-blind experimental study was conducted in 93 children with malaria, aged 4-10 years. Each was randomly allocated to one of the following groups: (1) treatment with antimalarial and retinol supplement (Group MA); (2) treatment with antimalarialretinol supplement and anti-parasitic drug (Group MAP); (3) treatment with antimalarial and antiparasitic drug (Group MP), and (4) treatment only with antimalarials (Group M). The groups were observed for 30 days, with haemoglobin, ferritin, retinol and C reactive protein evaluated on days 0, 8 and 30 after treatment.
Mean values for the children at day 0 were as follows: hemoglobin 10.3 +/- 1.6 g/dL, retinol 19.1 +/- 6.0 microg/dL, C reactive protein 75 +/- 63 mg/L and ferritin 213 +/- 203 microg/L. On day 30 after treatment, hemoglobin and plasma retinol concentrations increased in 1.4 +/- 1.4 g/dL and 11.5 +/- 8.1 microg/dL, whereas the C reactive protein and ferritin concentrations decreased to 66 +/- 60 mg/L, and 184 +/- 203 microg/L, respectively. No statistically significant differences appeared among the groups. On day 8, significant differences between the groups were observed in hemoglobin concentrations Group MAP was higher when compared to other groups.
On day 30, hemoglobin and retinol were high, whereas C reactive protein was low. Simultaneous administration of a retinol supplement and anti-parasite treatment prevented hemoglobin reduction observed on day 8 without changes in other variables.
疟疾、贫血和肠道寄生虫感染在哥伦比亚儿童的某些群体中可能同时存在。维生素A补充剂和抗肠道寄生虫治疗对患疟疾儿童的影响尚不清楚。此前尚未监测过这种治疗后血红蛋白、维生素A、铁蛋白和C反应蛋白水平的变化。
通过检测患疟疾儿童的血红蛋白、铁蛋白、维生素A和C反应蛋白水平,监测同时进行抗疟疾、补充维生素A和抗肠道寄生虫治疗的效果。
对93名4至10岁的患疟疾儿童进行了一项非盲实验研究。将每名儿童随机分配到以下组之一:(1) 接受抗疟疾和维生素A补充剂治疗(MA组);(2) 接受抗疟疾、维生素A补充剂和抗寄生虫药物治疗(MAP组);(3) 接受抗疟疾和抗寄生虫药物治疗(MP组);(4) 仅接受抗疟疾治疗(M组)。对这些组进行30天的观察,在治疗后第0、8和30天评估血红蛋白、铁蛋白、维生素A和C反应蛋白。
第0天儿童的平均值如下:血红蛋白10.3±1.6 g/dL,维生素A 19.1±6.0 μg/dL,C反应蛋白75±63 mg/L,铁蛋白213±203 μg/L。治疗后第30天,血红蛋白和血浆维生素A浓度分别增加了1.4±1.4 g/dL和11.5±8.1 μg/dL,而C反应蛋白和铁蛋白浓度分别降至66±60 mg/L和184±203 μg/L。各组之间未出现统计学上的显著差异。在第8天,观察到各组之间血红蛋白浓度存在显著差异,MAP组高于其他组。
在第30天,血红蛋白和维生素A水平较高,而C反应蛋白水平较低。同时给予维生素A补充剂和抗寄生虫治疗可防止第8天观察到的血红蛋白降低,而其他变量无变化。